These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6174998)

  • 1. Bladder outflow obstruction treated with phenoxybenzamine.
    Abrams PH; Shah PJ; Stone R; Choa RG
    Prog Clin Biol Res; 1981; 78():269-75. PubMed ID: 6174998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bladder outflow obstruction treated with phenoxybenzamine.
    Abrams PH; Shah PJ; Stone R; Choa RG
    Br J Urol; 1982 Oct; 54(5):527-30. PubMed ID: 6184106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenoxybenzamine reduces bladder outlet obstruction in benign prostatic hyperplasia. A urodynamic investigation.
    Gerstenberg T; Blaabjerg J; Nielsen ML; Clausen S
    Invest Urol; 1980 Jul; 18(1):29-31. PubMed ID: 6157651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pressure-to-cross-sectional area relationships in the proximal urethra of men with bladder outlet obstruction.
    Graversen PH; Bagi P; Tofft HP; Colstrup H; Kristensen JK
    J Urol; 1996 Jan; 155(1):267-70. PubMed ID: 7490852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia.
    Tanaka Y; Masumori N; Itoh N; Sato Y; Takahashi A; Ogura H; Furuya S; Tsukamoto T
    J Urol; 2002 Jun; 167(6):2492-5. PubMed ID: 11992065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction.
    Caine M; Perlberg S; Meretyk S
    Br J Urol; 1978 Dec; 50(7):551-4. PubMed ID: 88984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indoramin in the treatment of prostatic bladder outflow obstruction.
    Stott MA; Abrams P
    Br J Urol; 1991 May; 67(5):499-501. PubMed ID: 1710162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind controlled trial of a new alpha-1 blocking drug in the treatment of bladder outflow obstruction.
    Ramsay JW; Scott GI; Whitfield HN
    Br J Urol; 1985 Dec; 57(6):657-9. PubMed ID: 2417649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Obstruction of the lower urinary tract: contractile capacity of the detrusor and obstruction degree. Analysis of pressure/flow curves].
    Prieto Chaparro L; Rodríguez de Bethencourt F; Guil Cid M; Hontoria Briso J; Dehaini Dehaini A; Cruces de Abia F; Lera Fernández R; Salinas Casado J; Sánchez Chapado M
    Arch Esp Urol; 1995 Sep; 48(7):720-8. PubMed ID: 7487178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Rahardjo D; Soebadi DM; Sugandi S; Birowo P; Djati W; Wahyudi I
    Int J Urol; 2006 Nov; 13(11):1405-9. PubMed ID: 17083392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of passive urethral resistance relation and urethral resistance factor in analysis of bladder outlet obstruction in patients with benign prostatic enlargement.
    Rosier PF; de la Rosette JJ; de Wildt MJ; Debruyne FM; Wijkstra H
    Neurourol Urodyn; 1996; 15(1):1-10; discussion 10-5. PubMed ID: 8696351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study.
    Athanasopoulos A; Gyftopoulos K; Giannitsas K; Fisfis J; Perimenis P; Barbalias G
    J Urol; 2003 Jun; 169(6):2253-6. PubMed ID: 12771763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of pressure-flow analysis parameters in repeated cystometry in patients with benign prostatic hyperplasia.
    Rosier PF; de la Rosette JJ; Koldewijn EL; Debruyne FM; Wijkstra H
    J Urol; 1995 May; 153(5):1520-5. PubMed ID: 7536260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urodynamic and clinical effects of terazosin therapy in symptomatic patients with and without bladder outlet obstruction: a stratified analysis.
    Witjes WP; Rosier PF; Caris CT; Debruyne FM; de la Rosette JJ
    Urology; 1997 Feb; 49(2):197-205; discussion 205-6. PubMed ID: 9037281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of short-term treatment with the alpha 1-blocker alfuzosin on urodynamic pressure/flow parameters in patients with benign prostatic hyperplasia.
    Martorana G; Giberti C; Di Silverio F; von Heland M; Rigatti P; Colombo R; Casadei G; Pacifico P
    Eur Urol; 1997; 32(1):47-53. PubMed ID: 9266231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of clinical and pressure-flow study variables after 6 months of watchful waiting in patients with lower urinary tract symptoms and benign prostatic enlargement.
    Witjes WP; de Wildt MJ; Rosier PF; Caris CT; Debruyne FM; de la Rosette JJ
    J Urol; 1996 Sep; 156(3):1026-34. PubMed ID: 8709301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
    van Venrooij GE; Eckhardt MD; Boon TA
    Urology; 2004 Mar; 63(3):476-80. PubMed ID: 15028441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An observational urodynamic evaluation of men with lower urinary tract symptoms treated with doxazosin.
    Gerber GS; Kim JH; Contreras BA; Steinberg GD; Rukstalis DB
    Urology; 1996 Jun; 47(6):840-4. PubMed ID: 8677574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of primary bladder neck obstruction in women with transurethral resection of the bladder neck.
    Blaivas JG; Flisser A; Tash JA
    J Urol; 2004 Mar; 171(3):1172-5. PubMed ID: 14767294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urodynamic and clinical effects of noninvasive and minimally invasive treatments in elderly men with lower urinary tract symptoms stratified according to the grade of obstruction.
    Witjes WP; Robertson A; Rosier PF; Neal DE; Debruyne FM; de la Rosette JJ
    Urology; 1997 Jul; 50(1):55-61. PubMed ID: 9218019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.